HSA Bank Acquires Health Savings Accounts from Inland Bank and Trust
2022-11-17
并购
MILWAUKEE, Nov. 17, 2022 /PRNewswire/ -- HSA Bank, a division of Webster Bank, N.A., and Webster Financial Corporation (NYSE: WBS), the holding company for Webster Bank, N.A., announced today that it has acquired the health savings accounts (HSA) of Inland Bank and Trust. This acquisition offers Inland Bank and Trust's HSA accountholders new and easy ways to manage their healthcare spending and saving through an industry-leading HSA provider with more than two decades of experience.
Under the agreement, approximately 4,800 accounts, including an estimated $15.5 million in deposits, have transitioned from Inland Bank and Trust to HSA Bank, the nation's leading bank administrator and depository of HSAs. The transaction was subject to regulatory approval and customary closing conditions.
Current Inland Bank and Trust HSA accountholders do not need to take any action. Accountholders have received communications in advance of the transition.
About HSA Bank:
At HSA Bank, we're working toward a world where everyone is empowered to save for a healthy future. By providing the right tools and resources, we make it simple for our over 3 million members nationwide to maximize their savings for healthcare and long-term goals. As a leader in health accounts for over two decades, we continue to innovate. Our offerings in the healthcare savings space drive down healthcare costs, increase access, and assist with decision-making for consumers, health plans, partners, and advisors. As of September 30, 2022, HSA Bank had $11.1 billion in total footings comprising $7.9 billion in deposit balances and $3.2 billion in assets under administration through linked investment accounts and is a division of Webster Bank, N.A., Member FDIC Plan Administrative Services and Benefit Services are administered by Webster Servicing LLC. To learn more, visit hsabank.com.
Media Contact:
Webster Bank
(203) 578-2610
[email protected]
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。